Check-Cap Ltd

NASDAQ:CHEK  
0.89
-0.04 (-4.55%)
Products

Check-Cap Receives FDA IDE Approval For Pivotal Study Of C-Scan

Published: 03/15/2021 11:28 GMT
Check-Cap Ltd (CHEK) - Check-cap Receives FDA Ide Approval for Pivotal Study of C-scan®.
Check Cap Ltd - Expects to Commence U.S. Pivotal Trial in Late 2021.